CNS Pharmaceuticals Statistics

Total Valuation

CNSP has a market cap or net worth of $3.71 million. The enterprise value is -$3.46 million.

Market Cap	3.71M
Enterprise Value	-3.46M

Important Dates

The next estimated earnings date is Monday, March 31, 2025, after market close.

Earnings Date	Mar 31, 2025
Ex-Dividend Date	n/a

Share Statistics

CNSP has 1.15 million shares outstanding. The number of shares has increased by 9,861.66% in one year.

Current Share Class	1.15M
Shares Outstanding	1.15M
Shares Change (YoY)	+9,861.66%
Shares Change (QoQ)	+5,789.10%
Owned by Insiders (%)	46.61%
Owned by Institutions (%)	307.54%
Float	56.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.75
P/TBV Ratio	1.04
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.82, with a Debt / Equity ratio of 0.01.

Current Ratio	1.82
Quick Ratio	1.72
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,052.64

Financial Efficiency

Return on equity (ROE) is -2,116.75% and return on invested capital (ROIC) is -1,267.40%.

Return on Equity (ROE)	-2,116.75%
Return on Assets (ROA)	-219.28%
Return on Invested Capital (ROIC)	-1,267.40%
Return on Capital Employed (ROCE)	-509.53%
Revenue Per Employee	n/a
Profits Per Employee	-$3.41M
Employee Count	5
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -99.55% in the last 52 weeks. The beta is 1.02, so CNSP's price volatility has been similar to the market average.

Beta (5Y)	1.02
52-Week Price Change	-99.55%
50-Day Moving Average	5.32
200-Day Moving Average	77.04
Relative Strength Index (RSI)	35.21
Average Volume (20 Days)	941,090

Short Selling Information

Short Interest	3.63M
Short Previous Month	4.53M
Short % of Shares Out	n/a
Short % of Float	6.43%
Short Ratio (days to cover)	0.04

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-17.08M
Pretax Income	-17.46M
Net Income	-17.06M
EBITDA	-17.08M
EBIT	-17.08M
Earnings Per Share (EPS)	-$149.32

Full Income Statement

Balance Sheet

The company has $6.97 million in cash and $31,187 in debt, giving a net cash position of $6.94 million or $6.04 per share.

Cash & Cash Equivalents	6.97M
Total Debt	31,187
Net Cash	6.94M
Net Cash Per Share	$6.04
Equity (Book Value)	3.35M
Book Value Per Share	5.01
Working Capital	3.33M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$14.18 million and capital expenditures -$2,157, giving a free cash flow of -$14.18 million.

Operating Cash Flow	-14.18M
Capital Expenditures	-2,157
Free Cash Flow	-14.18M
FCF Per Share	-$12.33

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CNSP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9,861.66%
Shareholder Yield	-9,861.66%
Earnings Yield	-489.61%
FCF Yield	-407.07%

Analyst Forecast

The average price target for CNSP is $0.50, which is -84.52% lower than the current price. The consensus rating is "Strong Buy".

Price Target	$0.50
Price Target Difference	-84.52%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on June 5, 2024. It was a reverse split with a ratio of 0.02:1.

Last Split Date	Jun 5, 2024
Split Type	Reverse
Split Ratio	0.02:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2